Grimes, J. M., & Grimes, K. V. (2020). p38 MAPK inhibition: A promising therapeutic approach for COVID-19. Journal of molecular and cellular cardiology, 144, 63-65. https://doi.org/10.1016/j.yjmcc.2020.05.007
Chicago Style (17th ed.) CitationGrimes, Joseph M., and Kevin V. Grimes. "P38 MAPK Inhibition: A Promising Therapeutic Approach for COVID-19." Journal of Molecular and Cellular Cardiology 144 (2020): 63-65. https://doi.org/10.1016/j.yjmcc.2020.05.007.
MLA (9th ed.) CitationGrimes, Joseph M., and Kevin V. Grimes. "P38 MAPK Inhibition: A Promising Therapeutic Approach for COVID-19." Journal of Molecular and Cellular Cardiology, vol. 144, 2020, pp. 63-65, https://doi.org/10.1016/j.yjmcc.2020.05.007.
Warning: These citations may not always be 100% accurate.